EGFR and head and neck squamous cell carcinoma: As the tumor and its surrounding microenvironment can affect each other and the (extremely) low prevalence of EGFR and K-Ras mutations in HNSCC would likely preclude a major role for these mutations as predictive biomarker [24, 25], drug resistance might occur from the tumor microenvironment.